Portfolio Company · Operating Co.

Fortis Life Sciences

Healthcare & Life Sciences · Website

backed bySummit Partners

CurrentHealthcare & Life Sciences

a portfolio company of

Summit Partners

Status on record: Current

PE Firm Index

Who owns Fortis Life Sciences?

Fortis Life Sciences is listed as a current portfolio company of Summit Partners on Summit Partners' own portfolio page.

From the company's website

Fortis Life Sciences offers world-class reagents, tools, materials, and custom services for our research, diagnostic and therapeutic customers. Learn more here.

Source: fortislife.com, read November 2026

Company Snapshot

Fortis Life Sciences is a Healthcare & Life Sciences company. Its owner on record, Summit Partners, is a growth investing firm founded in 1984. Summit Partners lists 413 companies in the index, 50 of them in Healthcare & Life Sciences.

SectorHealthcare & Life Sciences

Parent PE firmSummit Partners

Ownership statusCurrent

WebsiteVisit ↗

About the owner

Summit Partners

Founded: 1984
Strategy: Growth investing, Minority partner, Majority partner, Strategic growth investment, Buy & Build strategy
Sectors: Technology, Healthcare & Life Sciences, Growth Products & Services
Companies in the index: 413

Summit Partners is a growth investment firm that seeks to invest in category-leading companies across technology, healthcare, life sciences, and growth products and services.

Read the Summit Partners profile

Questions about Fortis Life Sciences

Who owns Fortis Life Sciences?

Fortis Life Sciences is listed as a current portfolio company of Summit Partners on Summit Partners' own portfolio page.

What sector is Fortis Life Sciences in?

Fortis Life Sciences is in Healthcare & Life Sciences. Classified from the owner's portfolio label.

What else does Summit Partners own in Healthcare & Life Sciences?

Summit Partners lists 49 other Healthcare & Life Sciences companies in the index, including Abode Healthcare, Advance Health, Advanced Cell Diagnostics, AllerVie Health and American Dental Partners.

What is Fortis Life Sciences' website?

Fortis Life Sciences' website is https://www.fortislife.com/.

Sources

Summit Partners
https://www.summitpartners.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Fortis Life Sciences and does not provide investment advice.

Other portfolio companies of Summit Partners

6 of 412 shown

3 Day Blinds

Custom window coverings

360T Group

Technology

48forty Solutions

Growth Products & Services

A Cloud Guru

Technology

a.k.a. Brands

Growth Products & Services

A+ Network

Technology

See the full Summit Partners portfolio.

Other Healthcare & Life Sciences companies held by Summit Partners

Abode Healthcare Advance Health Advanced Cell Diagnostics AllerVie Health American Dental Partners AmeriPath

Other Healthcare & Life Sciences portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Summit Partners

Status: Current

Check this company's website

Check this company's website now

Free, in about two minutes: the verified issues a buyer or a customer's browser would meet. Runs on GTM Brain, by DevriX.

Observational measurements of this company's public website only. Not a rating of the company, its performance, its management, or its investment merit. Not investment advice. Request a correction or removal via Submit Update.

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.